On the use of wearable sensors as mobility biomarkers in the marketing authorization of new drugs: A regulatory perspective

On the use of wearable sensors as mobility biomarkers in the marketing authorization of new drugs: A regulatory perspective

The loss of mobility is a common trait in multiple health conditions (e.g., Parkinson's disease) and is associated with reduced quality of life. In this context, being able to monitor mobility in the real world, is important. Until recently, the technology was not mature enough for this; but to...

Full description

Bibliographic Details
Main Authors: Marco Viceconti, Maria Tome, Wilhelmus Dartee, Igor Knezevic, Sabina Hernandez Penna, Claudia Mazzà, Brian Caulfield, Judith Garcia-Aymerich, Clemens Becker, Walter Maetzler, Thierry Troosters, Basil Sharrack, Giorgio Davico, Solange Corriol-Rohou, Lynn Rochester, the Mobilise-D Consortium
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Medicine
Subjects:
digital mobility outcomes
regulatory qualification
mobility biomarkers
wearable sensors
mobility disability
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.996903/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.996903/full

Similar Items